Ondine Biomedical Investor Relations Material
Latest events
H1 2024
Ondine Biomedical
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Ondine Biomedical Inc
Access all reports
Ondine Biomedical Inc. is a life sciences company specializing in the development of photodisinfection-based therapies. These innovative therapies are designed to provide solutions for a wide range of infections, including those resistant to antibiotics. The company's focus is on creating non-antibiotic anti-infective treatments for bacterial, viral, and fungal infections, leveraging its patented light-activated technology. Ondine Biomedical Inc.'s approach represents a significant advancement in addressing the global challenge of drug-resistant infections, offering potential benefits in both healthcare settings and beyond. The company is headquartered in Vancouver, Canada, and its shares are listed on the London Stock Exchange.
Key slides for Ondine Biomedical Inc
H2 2023
Ondine Biomedical Inc
H1 2024
Ondine Biomedical Inc
Latest articles
Prada: The Story of an Icon
Prada's journey from a small Milan boutique to a global luxury empire, led by Miuccia's innovation and creativity.
5 Dec 2024
Hims & Hers: Bridging Gaps in Telehealth
Hims & Hers was founded in 2016 by Andrew Dudum and has grown into a ~$4 billion company in the telehealth industry in less than a decade.
5 Dec 2024
Andrew Dudum: Founder and CEO of Hims & Hers
Andrew Dudum is the founder and CEO of Hims & Hers, an innovative telehealth company focused on bridging the gap between consumers and healthcare.
4 Dec 2024
Ticker symbol
OBI
Country
🇬🇧 United Kingdom